Cell and Gene Therapy Catapult Seminar Day - Bristol

External Event - 20th Jun 2019

9:00 - 16:30

School of Chemistry, Cantock's Close, Bristol, BS8 1TS

The Cell and Gene Therapy (CGT) Catapult and the University of Bristol invite you to take part in a one-day seminar event for biomedical researchers.

The day comprises a series of morning talks covering key considerations for translation and commercialisation of cell and gene therapy research, understanding how to ensure commercial success for your advanced therapy projects.

Talks will be followed by afternoon 1:1 clinics with CGT Catapult’s own experts spanning how to address current and future pre-clinical and clinical ATMP development needs, regulatory and reimbursement challenges, and addressing barriers to scale-up manufacturing. The full programme is listed below.

Please indicate if you would like to receive tailored feedback on a project idea during the registration process by giving a brief summary of your project and questions you would like to discuss with our experts.

Spaces are limited; register for your free place here

09.00-09.30, Breakfast and registration
09.30-10.00, Welcome and introduction to the Cell and Gene Therapy Catapult, Dr Kerstin Papenfuss, University Liaison Manager
10.00-10.30, Understanding your pre-clinical data package needs, Dr Julie Tordo, Senior Non-Clinical Study Manager
10.30-11.00, Regulatory considerations for clinical translation of ATMPs, Dr Patrick Ginty, Head of Regulatory Affairs
11.00-11.30, Networking coffee break
11.30-12.00, Process scaling and manufacturing, Dr Jonathan Appleby, Chief Scientific Officer
12.00-12.30, Protecting inventions and understanding freedom to operate, Dr Jodie Albutt, Head of Intellectual Property
12.30-13.00, The importance of planning for ATMP reimbursement early, Jesper Jorgensen, Health Economics and Market Access Manager
13.00-13.45, Lunch and networking
13.45-16.30, 1:1 advisory and feedback clinics

The Cell and Gene Therapy Catapult is a centre of excellence in innovation, with the core purpose of building a world-leading cell and gene therapy sector in the UK as a key part of a global industry. Supported by Innovate UK, our mission is to drive the growth of the industry by helping cell and gene therapy organisations across the world translate early stage research into commercially viable and investable therapies. We are based on the 12th floor of Guy’s Hospital in central London, with over 180 cell and gene therapy experts, state-of-the-art development and viral vector laboratories. We are also building a £55m large-scale GMP manufacturing centre to help bring cell and gene therapies to market in the UK and internationally.

For more information, click here

Add event to Google Calendar